Luteolin Alleviates Renal Fibrosis in Diabetic Kidney Disease via Activation of the Cx32‐Nrf2 Signaling Axis
Phytotherapy Research · 10.11.2026
DOI: 10.1002/ptr.70507 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 10.11.2026. Verfasst von Shuang Liang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, Guangxi Medical University, Nanning, Guangxi, People's Republic of China. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangxi Natural Science Foundation, National Natural Science Foundation of China, Natural Science Foundation of Guangxi Zhuang Autonomous Region.
Abstract (Originalsprache)
Luteolin (Lut) is a flavonoid found in many medicinal plants, and previous studies have shown that it can slow the progression of diabetic kidney disease (DKD), although the mechanism is incompletely defined. This study asked whether Lut protects against DKD by acting on the connexin32 (Cx32)‐Nrf2 signaling axis to suppress ferroptosis and partial epithelial‐mesenchymal transition (EMT). Renal fibrosis, oxidative stress, EMT, and ferroptosis related markers, as well as Cx32/Nrf2 expression were assessed in db/db mice and high glucose (HG)‐induced NRK‐52E cells. Microdissected human kidney transcriptomes were obtained from GEO and analyzed in R. Molecular docking and cellular thermal shift assay (CETSA) were used to test whether Lut interacts with Cx32. siRNA knockdown was used to test whether Cx32 is required for its effects. Lut improved renal function, reduced fibrosis, lowered ROS, EMT, and ferroptosis in db/db mice and HG‐induced NRK‐52E cells. Additionally, Cx32 and Nrf2 protein levels were reduced, which was restored by Lut treatment. And overexpression of Cx32 promoted Nrf2 nuclear translocation. In human diabetic kidney transcriptomes, Cx32 and Nrf2 transcripts changed reciprocally and were inversely correlated across two independent cohorts, supporting Cx32 as a candidate upstream node. Molecular docking indicated that Lut binds to the ARG22 and THR18 residues of Cx32, and CETSA showed that Lut increased the thermal stability of Cx32. Knockdown of Cx32 abolished Nrf2 activation by Lut. Therefore, we concluded that Lut attenuates renal fibrosis in DKD by activating the Cx32‐Nrf2 signaling axis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, School of Pharmacy, Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
- University Engineering Research Center of Prevention and Treatment of Major Diseases in the Elderly and Biomedical Translation, Nanning, Guangxi, China.
- Guangxi Key Laboratory of Bioactive Molecules Research and Evaluation, School of Pharmacy, Guangxi Medical University, Nanning, China.
- Chulalongkorn University, Bangkok, Thailand.
ORCID-Profile: Yuan He
Förderung
- Guangxi Natural Science Foundation
- National Natural Science Foundation of China
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
Zitieren
APA
Liang, S., Nong, Q., Chen, Y., He, Y., Feng, T., Chen, G., Zhang, Q., Liu, Z., Ou, G., Tang, D., Jiao, Y., & Chen, Z. (2026). Luteolin Alleviates Renal Fibrosis in Diabetic Kidney Disease via Activation of the Cx32‐Nrf2 Signaling Axis. Phytotherapy Research. https://doi.org/10.1002/ptr.70507
Vancouver
Liang S, Nong Q, Chen Y, He Y, Feng T, Chen G, et al. Luteolin Alleviates Renal Fibrosis in Diabetic Kidney Disease via Activation of the Cx32‐Nrf2 Signaling Axis. Phytotherapy Research. 2026. doi:10.1002/ptr.70507
BibTeX
@article{Liang2026,
author = {Liang, Shuang and Nong, Qiudong and Chen, Yeyi and He, Yuan and Feng, Ting and Chen, Guitian and Zhang, Qingshao and Liu, Zhiying and Ou, Guoqi and Tang, Dezhe and Jiao, Yang and Chen, Zhiquan},
title = {Luteolin Alleviates Renal Fibrosis in Diabetic Kidney Disease via Activation of the Cx32‐Nrf2 Signaling Axis},
journal = {Phytotherapy Research},
year = {2026},
doi = {10.1002/ptr.70507}
}
EUVIMED